Century Therapeutics (IPSC) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.14%.
- Century Therapeutics' Return on Capital Employed rose 2400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.61% for FY2024, which is 2500.0% down from last year.
- Per Century Therapeutics' latest filing, its Return on Capital Employed stood at 0.14% for Q3 2025, which was up 2400.0% from 0.11% recorded in Q2 2025.
- In the past 5 years, Century Therapeutics' Return on Capital Employed registered a high of 0.1% during Q1 2025, and its lowest value of 0.57% during Q4 2024.
- Over the past 4 years, Century Therapeutics' median Return on Capital Employed value was 0.33% (recorded in 2023), while the average stood at 0.32%.
- In the last 5 years, Century Therapeutics' Return on Capital Employed tumbled by -1700bps in 2024 and then soared by 3300bps in 2025.
- Century Therapeutics' Return on Capital Employed (Quarter) stood at 0.29% in 2022, then plummeted by -42bps to 0.41% in 2023, then plummeted by -41bps to 0.57% in 2024, then soared by 76bps to 0.14% in 2025.
- Its Return on Capital Employed was 0.14% in Q3 2025, compared to 0.11% in Q2 2025 and 0.1% in Q1 2025.